Hainan Puli Pharmaceutical Co., Ltd. announced that due to the inability of Hainan Puli Pharmaceutical Co., Ltd. to disclose the 2023 annual report and the first quarter report of 2024 within the legal period (April 30, 2024), trading of the company's shares and convertible corporate bonds (bond abbreviation: Pulley Convertible, Bond Code: 123099) will be suspended from May 6, 2024. According to regulations: “Where stock trading of a listed company is suspended and resumed, trading of its convertible bonds is suspended or resumed at the same time.” As a result, during the stock suspension period, “Pulley Convertible Bonds” was suspended and stock conversion was suspended.
普利制药：“普利转债”2024年5月6日起停牌及暂停转股
Puli Pharmaceuticals: “Priori Bonds” will be suspended from trading and stock conversion will be suspended from May 6, 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.